ISRCTN04840953
Completed
未知
Münster tinnitus randomized controlled clinical trial-2013 based on Tailor-Made Notched Music Treatment (TMNMT)
niversity of Münster (Germany)0 sites100 target enrollmentJune 25, 2013
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Optimal individual matching of the TMNMT profile
- Sponsor
- niversity of Münster (Germany)
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Adult patients with chronic (\= 3 months) tonal (i.e. peep\- or whistle\-like) tinnitus, and without severe hearing loss (\= 65 dB HL) in the frequency ranges of one half octave above and below the tinnitus frequency.
- •2\. Aged between 18 and 70 years
- •3\. Written informed consent to participate in the trial
Exclusion Criteria
- •1\. Tinnitus patients who do not have severe neurological or psychiatric disorders (e.g. amnesia, dementia, depression, epilepsy, etc) that could limit their capability or result in major difficulties regarding the patients' motivational compliance or limit their ability to follow instructions or to participate in the training.
- •2\. Planned start of other rehabilitation therapies that might interfere with this trial, or participation in another clinical trial, or insufficient motivation to participate.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Low-intensity TUS for Sleep Disturbances in Patients With Chronic TinnitusNCT06776705Chinese University of Hong Kong14
Completed
Not Applicable
A Study on the Effect of Cilostazol in Patients With Chronic TinnitusTinnitusNCT01378650Jong Woo Chung50
Completed
Phase 2
Mindfulness Based Tinnitus Reduction (MBTR): A Symptom Perception Shift ProgramTinnitusAnxietyDepressionNCT01229709University of California, San Francisco10
Completed
Not Applicable
Trial of a tinnitus treatment platform based on Personalised Sound TherapyTinnitusEar - Other ear disordersACTRN12621000389808The University of Auckland99
Completed
Phase 2
Neramexane for TinnitusTinnitusNCT00405886Merz Pharmaceuticals GmbH431